Product Name
Filaggrin (FLG), Monoclonal Antibody
Popular Item
Full Product Name
Filaggrin
Product Synonym Names
Mouse anti-Human Filaggrin
Product Gene Name
anti-FLG antibody
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Chromosome Location
Chromosome: 1; NC_000001.10 (152274651..152297679, complement). Location: 1q21.3
3D Structure
ModBase 3D Structure for P20930
Specificity
Recognizes human Filaggrin.
Purity/Purification
Affinity Purified
Purified by Protein G affinity chromatography.
Form/Format
Supplied as a liquid in 10mM PBS, pH 7.4, 0.2% BSA and 0.09% sodium azide
Concentration
0.2 mg/ml (lot specific)
Immunogen
Recombinant protein corresponding to human
Cellular Localization
Cytoplasmic
Preparation and Storage
May be stored at 4 degree C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months after receipt. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
Other Notes
Small volumes of anti-FLG antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
anti-FLG antibody
Filaggrins are an important class of the intermediate filament-associated proteins which interect with keratin intermediate filaments (Ifs) of terminally differentiating mammalian epidermis. Filaggrins exhibit wide species variations. Filaggrin also appears to be a target molecule for rheumatoid arthritis-specific auto-antibodies in humans. Filaggrin is expressed only in well differemtiated keratinized epithelial cells. The synthesis of filaggrin varies in types of ichthyosis, and with viral, premalignant and malignant conditions.
Product Categories/Family for anti-FLG antibody
Antibodies; Abs to Proteins
Applications Tested/Suitable for anti-FLG antibody
Immunohistochemistry (IHC)
Other applications not tested
Application Notes for anti-FLG antibody
Recommended Dilution:
Immunohistology (FFPE): (2-4ug/ml for 30 min at RT). Staining of formalin-fixed tissues REQUIRES boiling tissue sections in 10mM citrate buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 min.
Optimal dilutions to be determined by the researcher.
Immunohistochemistry of anti-FLG antibody
Immunohistochemistry analysis in formalin-fixed, paraffin-embedded human skin stained with MBS603861 using peroxidase-conjugate and AEC chromogen. Note cytoplasmic staining of keratinized epithelial cells of hair follicle.

NCBI/Uniprot data below describe general gene information for FLG. It may not necessarily be applicable to this product.
NCBI Accession #
NP_002007.1
[Other Products]
NCBI GenBank Nucleotide #
NM_002016.1
[Other Products]
UniProt Primary Accession #
P20930
[Other Products]
UniProt Secondary Accession #
Q01720; Q5T583; Q9UC71[Other Products]
UniProt Related Accession #
O75370; P20930; Q03837; Q03838; Q03839; Q05331; Q15206; Q16824; Q4JFL9; Q59H78[Other Products]
Molecular Weight
38kD (Filaggrin) and 400kD (Profilaggrin)[Similar Products]
NCBI Official Full Name
filaggrin
NCBI Official Synonym Full Names
filaggrin
NCBI Official Symbol
FLG??[Similar Products]
NCBI Official Synonym Symbols
ATOD2
??[Similar Products]
NCBI Protein Information
filaggrin; OTTHUMP00000014057; epidermal filaggrin
UniProt Protein Name
Filaggrin
UniProt Gene Name
FLG??[Similar Products]
UniProt Entry Name
FILA_HUMAN
NCBI Summary for FLG
The protein encoded by this gene is an intermediate filament-associated protein that aggregates keratin intermediate filaments in mammalian epidermis. It is initially synthesized as a polyprotein precursor, profilaggrin (consisting of multiple filaggrin units of 324 aa each), which is localized in keratohyalin granules, and is subsequently proteolytically processed into individual functional filaggrin molecules. Mutations in this gene are associated with ichthyosis vulgaris.
UniProt Comments for FLG
FLG: Aggregates keratin intermediate filaments and promotes disulfide-bond formation among the intermediate filaments during terminal differentiation of mammalian epidermis. Defects in FLG are the cause of ichthyosis vulgaris (VI); also known as ichthyosis simplex. Ichthyosis vulgaris is the most common form of ichthyosis inherited as an autosomal dominant trait. It is characterized by palmar hyperlinearity, keratosis pilaris and a fine scale that is most prominent over the lower abdomen, arms, and legs. Ichthyosis vulgaris is characterized histologically by absent or reduced keratohyalin granules in the epidermis and mild hyperkeratosis. The disease can be associated with frequent asthma, eczema or hay fever. Defects in FLG are a cause of susceptibility to dermatitis atopic type 2 (ATOD2). Atopic dermatitis is a complex, inflammatory disease with multiple alleles at several loci thought to be involved in the pathogenesis. It commonly begins in infancy or early childhood and is characterized by a chronic relapsing form of skin inflammation, a disturbance of epidermal barrier function that culminates in dry skin, and IgE- mediated sensitization to food and environmental allergens. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. Belongs to the S100-fused protein family.
Protein type: Cytoskeletal
Chromosomal Location of Human Ortholog: 1q21.3
Cellular Component: cytoplasmic membrane-bound vesicle; intermediate filament; nucleus
Molecular Function: protein binding; calcium ion binding; structural molecule activity
Biological Process: keratinocyte differentiation; multicellular organismal development
Disease: Ichthyosis Vulgaris; Dermatitis, Atopic, 2
Research Articles on FLG
1. Filaggrin null mutations are not a protective factor for acne vulgaris.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.